MTOR and hepatocellular carcinoma: Therefore, the m6A modification and the P53 pathway, Wnt/β-Catenin pathway, and PI3K/AKT/mTOR pathway may be collectively associated with the modulation of the tumor microenvironment and immune response in different HCC clusters.